- English (USA)
- English (UK)
- English (India)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Cosmos Pharmaceutical Corp (3349)
Cosmos Pharmaceutical Corp stock price live, this page displays TYO 3349 stock exchange data. View the 3349 premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the Cosmos Pharmaceutical Corp real time stock price chart below.
What Is the Cosmos Pharmaceutical Corp Stock Price Today?
The Cosmos Pharmaceutical Corp stock price today is 9,305.0.
What Is the Stock Symbol for Cosmos Pharmaceutical Corp?
The stock symbol for Cosmos Pharmaceutical Corp is ""3349.""
What Stock Exchange Does Cosmos Pharmaceutical Corp Trade On?
Cosmos Pharmaceutical Corp is listed and trades on the Tokyo stock exchange.
Is Cosmos Pharmaceutical Corp a Good Stock to Buy?
Determining whether Cosmos Pharmaceutical Corp—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the 3349 quote. (ISIN: JP3298400007)
What Is the Cosmos Pharmaceutical Corp Stock Price Today?
The Cosmos Pharmaceutical Corp stock price today is 9,305.0.
What Is the Stock Symbol for Cosmos Pharmaceutical Corp?
The stock symbol for Cosmos Pharmaceutical Corp is ""3349.""
What Stock Exchange Does Cosmos Pharmaceutical Corp Trade On?
Cosmos Pharmaceutical Corp is listed and trades on the Tokyo stock exchange.
Is Cosmos Pharmaceutical Corp a Good Stock to Buy?
Determining whether Cosmos Pharmaceutical Corp—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the 3349 quote. (ISIN: JP3298400007)
Tokyo
Currency in JPY
9,305.0
+72.0(+0.78%)
Closed·
Fair Value
An estimate of a Cosmos Pharmaceutical Corp's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
9,157.0
9,391.0
52 wk Range
5,777.5
9,726.0
3349 Scorecard
Full Analysis
Trading at a high P/E ratio relative to near-term earnings growth
3349 is not included in our AI-picked strategies. See which stocks are.
Review Strategies
Fair Value
An estimate of a Cosmos Pharmaceutical Corp's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
9,157.09,391.0
52 wk Range
5,777.59,726.0
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
(0.70%)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
(0.70%)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
3349 Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a Cosmos Pharmaceutical Corp's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PricePrice Target
9,629.2
Upside
+3.48%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Prominent player in the Consumer Staples Distribution & Retail industry
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Sell
Cosmos Pharmaceutical Corp Company Profile
COSMOS Pharmaceutical Corporation engages in the retail sale of pharmaceuticals, cosmetics, daily necessities, food, etc. in Japan. It also sells its products through online stores. The company was incorporated in 1983 and is headquartered in Fukuoka City, Japan.
Compare 3349 to Peers and Sector
Metrics to compare | 3349 | Sector Sector - Average of metrics from a broad group of related Consumer Non-Cyclicals sector companies | Relationship Relationship3349PeersSector | |
|---|---|---|---|---|
P/E Ratio | 25.1x | 13.3x | 12.0x | |
PEG Ratio | 1.37 | 0.08 | 0.03 | |
Price/Book | 3.0x | 1.2x | 1.5x | |
Price / LTM Sales | 0.7x | 0.2x | 0.9x | |
Upside (Analyst Target) | −0.3% | 0.1% | 17.9% | |
Fair Value Upside | Unlock | 18.3% | 10.8% | Unlock |
Analyst Ratings
5 Buy
6 Hold
1 Sell
Ratings:
12 analysts
Overall Consensus
Buy
Analysts 12-Month Price Target:
Average 9,629.2
(+3.48% Upside)
Earnings
Latest Release
Jul 11, 2025
EPS / Forecast
-- / 114.27
Revenue / Forecast
-- / 258.55B
People Also Watch
FAQ
What Stock Exchange Does Cosmos Pharmaceutical Corp Trade On?
Cosmos Pharmaceutical Corp is listed and trades on the Tokyo Stock Exchange stock exchange.
What Is the Stock Symbol for Cosmos Pharmaceutical Corp?
The stock symbol for Cosmos Pharmaceutical Corp is "3349."
What Is the Cosmos Pharmaceutical Corp Market Cap?
As of today, Cosmos Pharmaceutical Corp market cap is 737.49B.
What Is Cosmos Pharmaceutical Corp's Earnings Per Share (TTM)?
The Cosmos Pharmaceutical Corp EPS (TTM) is 371.45.
When Is the Next Cosmos Pharmaceutical Corp Earnings Date?
Cosmos Pharmaceutical Corp will release its next earnings report on 09 Oct 2025.
From a Technical Analysis Perspective, Is 3349 a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Buy.
How Many Times Has Cosmos Pharmaceutical Corp Stock Split?
Cosmos Pharmaceutical Corp has split 3 times.
How Many Employees Does Cosmos Pharmaceutical Corp Have?
Cosmos Pharmaceutical Corp has 5512 employees.
What is the current trading status of Cosmos Pharmaceutical Corp (3349)?
As of 13 Jul 2025, Cosmos Pharmaceutical Corp (3349) is trading at a price of 9,305.00, with a previous close of 9,233.00. The stock has fluctuated within a day range of 9,157.00 to 9,391.00, while its 52-week range spans from 5,777.50 to 9,726.00.
What Is Cosmos Pharmaceutical Corp (3349) Price Target According to Analysts?
The average 12-month price target for Cosmos Pharmaceutical Corp is JPY9629.16667, with a high estimate of JPY11200 and a low estimate of JPY8000. 5 analysts recommend buying the stock, while 1 suggest selling, leading to an overall rating of Buy. The stock has an +3.48% Upside potential.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.